David A. Tate

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

Stanley D. Bleich, Timothy C. Nichols, Richard R. Schumacher et al. · The American Journal of Cardiology · 1990 · 267 citations

Medicine, Cardiology, Pharmacotherapy +16

Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure

Efthymios Deliargyris, Ronald J. Raymond, Theoharis C. Theoharides et al. · The American Journal of Cardiology · 2000 · 84 citations

Medicine, Cardiology, Immunology +12

Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans

Gregory Dehmer, Melrose Fisher, David A. Tate et al. · Circulation · 1995 · 62 citations

Medicine, Hematology, Pharmacology +17

von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis.

Timothy C. Nichols, Dwight A. Bellinger, David A. Tate et al. · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1990 · 60 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12

Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents

Gregory Dehmer, Nancy J. Gresalfi, Dale Daly et al. · Journal of the American College of Cardiology · 1995 · 38 citations

Medicine, Pharmacology, Hemostasis +10